LQDA
Liquidia Corp
Key Financials
Operating Income
$-51376000
↑ 57.6%
Revenue
$158.3M
↑ 1031.2%
Net Income
$-68924000
↑ 47.1%
Total Liabilities
$283.2M
↑ 85.0%
EPS (Diluted)
$-0.80
↑ 51.8%
Total Assets
$327.9M
↑ 42.4%
Cash & Equivalents
$190.7M
↑ 8.0%
Shareholders' Equity
$44.7M
↓ 42.1%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 4 | 5/20/2026 | View on SEC |
| 4 | 5/20/2026 | View on SEC |
| 144 | 5/20/2026 | View on SEC |
| 4 | 5/15/2026 | View on SEC |
| 144 | 5/14/2026 | View on SEC |
| 4 | 5/13/2026 | View on SEC |
| 4 | 5/12/2026 | View on SEC |
| 144 | 5/11/2026 | View on SEC |
| 10-Q | 5/11/2026 | View on SEC |
| 8-K | 5/11/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | LQDA |
| Company Name | Liquidia Corp |
| CIK | 1819576 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 919.328.4400 |